Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
WASF3 |
WAS protein family, member 3, transcript variant 1 |
FXC00143
|
FHC00143
|
FNC00143N
|
FNC00143C
|
TJP1 |
tight junction protein 1 |
FXC00318
|
FHC00318
|
FNC00318N
|
FNC00318C
|
WASF1 |
WAS protein family, member 1, transcript variant 1 |
FXC00484
|
FHC00484
|
FNC00484N
|
FNC00484C
|
RNMT |
RNA (guanine-7-) methyltransferase, transcript variant 2 |
FXC00528
|
FHC00528
|
FNC00528N
|
FNC00528C
|
SSX2IP |
synovial sarcoma, X breakpoint 2 interacting protein, transcript variant 5 |
FXC00684
|
FHC00684
|
FNC00684N
|
FNC00684C
|
FZR1 |
fizzy/cell division cycle 20 related 1, transcript variant 2 |
FXC00776
|
FHC00776
|
FNC00776N
|
FNC00776C
|
IQGAP1 |
IQ motif containing GTPase activating protein 1 |
FXC01050
|
FHC01050
|
FNC01050N
|
FNC01050C
|
CTNND1 |
catenin (cadherin-associated protein), delta 1, transcript variant 4 |
FXC01078
|
FHC01078
|
FNC01078N
|
FNC01078C
|
PTPRF |
protein tyrosine phosphatase, receptor type, F, transcript variant 2 |
FXC01213
|
FHC01213
|
FNC01213N
|
FNC01213C
|
TGFBR1 |
transforming growth factor, beta receptor 1, transcript variant 1 |
FXC01305
|
FHC01305
|
FNC01305N
|
FNC01305C
|
NLK |
nemo-like kinase |
FXC01310
|
FHC01310
|
FNC01310N
|
FNC01310C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa), transcript variant 2 |
FXC01401
|
FHC01401
|
FNC01401N
|
FNC01401C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
RHOA |
ras homolog family member A |
FXC01522
|
FHC01522
|
FNC01522N
|
FNC01522C
|
ACTB |
actin, beta |
FXC01523
|
FHC01523
|
FNC01523N
|
FNC01523C
|
NCOA3 |
nuclear receptor coactivator 3, transcript variant 3 |
FXC01529
|
FHC01529
|
FNC01529N
|
FNC01529C
|
PTPN1 |
protein tyrosine phosphatase, non-receptor type 1, transcript variant 1 |
FXC01557
|
FHC01557
|
FNC01557N
|
FNC01557C
|
SMAD4 |
SMAD family member 4 |
FXC01560
|
FHC01560
|
FNC01560N
|
FNC01560C
|
CTNNA1 |
catenin (cadherin-associated protein), alpha 1, 102kDa, transcript variant 1 |
FXC01564
|
FHC01564
|
FNC01564N
|
FNC01564C
|
IGF1R |
insulin-like growth factor 1 receptor, transcript variant 2 |
FXC01578
|
FHC01578
|
FNC01578N
|
FNC01578C
|
EP300 |
E1A binding protein p300 |
FXC01787
|
FHC01787
|
FNC01787N
|
FNC01787C
|
ACP1 |
acid phosphatase 1, soluble, transcript variant 3 |
FXC01817
|
FHC01817
|
FNC01817N
|
FNC01817C
|
VCL |
vinculin, transcript variant 2 |
FXC01835
|
FHC01835
|
FNC01835N
|
FNC01835C
|
YES1 |
YES proto-oncogene 1, Src family tyrosine kinase |
FXC01863
|
FHC01863
|
FNC01863N
|
FNC01863C
|
SORBS1 |
sorbin and SH3 domain containing 1, transcript variant 6 |
FXC02027
|
FHC02027
|
FNC02027N
|
FNC02027C
|
SNAI1 |
snail family zinc finger 1 |
FXC02510
|
FHC02510
|
FNC02510N
|
FNC02510C
|
SNAI2 |
snail family zinc finger 2 |
FXC02514
|
FHC02514
|
FNC02514N
|
FNC02514C
|
SMAD3 |
SMAD family member 3, transcript variant 1 |
FXC02648
|
FHC02648
|
FNC02648N
|
FNC02648C
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1), transcript variant Rac1 |
FXC02699
|
FHC02699
|
FNC02699N
|
FNC02699C
|
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
FXC02856
|
FHC02856
|
FNC02856N
|
FNC02856C
|
SMAD2 |
SMAD family member 2, transcript variant 1 |
FXC03382
|
FHC03382
|
FNC03382N
|
FNC03382C
|
WASF2 |
WAS protein family, member 2, transcript variant 1 |
FXC03721
|
FHC03721
|
FNC03721N
|
FNC03721C
|
PVRL1 |
poliovirus receptor-related 1 (herpesvirus entry mediator C), transcript variant 1 |
FXC03817
|
FHC03817
|
FNC03817N
|
FNC03817C
|
FER |
fer (fps/fes related) tyrosine kinase, transcript variant 1 |
FXC03985
|
FHC03985
|
FNC03985N
|
FNC03985C
|
CSNK2A2 |
casein kinase 2, alpha prime polypeptide |
FXC04660
|
FHC04660
|
FNC04660N
|
FNC04660C
|
CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa, transcript variant 1 |
FXC07714
|
FHC07714
|
FNC07714N
|
FNC07714C
|
ACTG1 |
actin gamma 1, transcript variant 2 |
FXC07847
|
FHC07847
|
FNC07847N
|
FNC07847C
|
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6, transcript variant 2 |
FXC08074
|
FHC08074
|
FNC08074N
|
FNC08074C
|
GPI |
glucose-6-phosphate isomerase, transcript variant 2 |
FXC08209
|
FHC08209
|
FNC08209N
|
FNC08209C
|
ACTN4 |
actinin, alpha 4 |
FXC08216
|
FHC08216
|
FNC08216N
|
FNC08216C
|
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
FXC08439
|
FHC08439
|
FNC08439N
|
FNC08439C
|
CSNK2A1 |
casein kinase 2, alpha 1 polypeptide, transcript variant 2 |
FXC08568
|
FHC08568
|
FNC08568N
|
FNC08568C
|
WAS |
Wiskott-Aldrich syndrome |
FXC08646
|
FHC08646
|
FNC08646N
|
FNC08646C
|
ACTN1 |
actinin, alpha 1, transcript variant 2 |
FXC08813
|
FHC08813
|
FNC08813N
|
FNC08813C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
PVRL4 |
poliovirus receptor-related 4 |
FXC09961
|
FHC09961
|
FNC09961N
|
FNC09961C
|
FGFR1 |
fibroblast growth factor receptor 1, transcript variant 3 |
FXC10532
|
FHC10532
|
FNC10532N
|
FNC10532C
|
MAP3K7 |
mitogen-activated protein kinase kinase kinase 7, transcript variant A |
FXC10678
|
FHC10678
|
FNC10678N
|
FNC10678C
|
FYN |
FYN proto-oncogene, Src family tyrosine kinase, transcript variant 1 |
FXC10684
|
FHC10684
|
FNC10684N
|
FNC10684C
|
PVRL2 |
poliovirus receptor-related 2 (herpesvirus entry mediator B), transcript variant delta |
FXC10685
|
FHC10685
|
FNC10685N
|
FNC10685C
|
BAIAP2 |
BAI1-associated protein 2, transcript variant 2 |
FXC10688
|
FHC10688
|
FNC10688N
|
FNC10688C
|
PTPRB |
protein tyrosine phosphatase, receptor type, B, transcript variant 1 |
FXC10714
|
FHC10714
|
FNC10714N
|
FNC10714C
|
ACTN2 |
actinin, alpha 2, transcript variant 1 |
FXC11021
|
FHC11021
|
FNC11021N
|
FNC11021C
|
INSR |
insulin receptor, transcript variant 2 |
FXC11132
|
FHC11132
|
FNC11132N
|
FNC11132C
|
CDC42 |
cell division cycle 42, transcript variant 2 |
FXC11496
|
FHC11496
|
FNC11496N
|
FNC11496C
|
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box), transcript variant 4 |
FXC11660
|
FHC11660
|
FNC11660N
|
FNC11660C
|
CTNNA2 |
catenin (cadherin-associated protein), alpha 2, transcript variant 1 |
FXC11771
|
FHC11771
|
FNC11771N
|
FNC11771C
|
CREBBP |
CREB binding protein, transcript variant 1 |
FXC11778
|
FHC11778
|
FNC11778N
|
FNC11778C
|
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
FXC11836
|
FHC11836
|
FNC11836N
|
FNC11836C
|
SRC |
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant 1 |
FXC11854
|
FHC11854
|
FNC11854N
|
FNC11854C
|
WASL |
Wiskott-Aldrich syndrome-like |
FXC11943
|
FHC11943
|
FNC11943N
|
FNC11943C
|
MET |
MET proto-oncogene, receptor tyrosine kinase, transcript variant 2 |
FXC12649
|
FHC12649
|
FNC12649N
|
FNC12649C
|
PARD3 |
par-3 family cell polarity regulator, transcript variant 2 |
FXC12690
|
FHC12690
|
FNC12690N
|
FNC12690C
|
LEF1 |
lymphoid enhancer-binding factor 1, transcript variant 2 |
FXC16601
|
FHC16601
|
FNC16601N
|
FNC16601C
|
TCF7L1 |
transcription factor 7-like 1 (T-cell specific, HMG-box) |
FXC21071
|
FHC21071
|
FNC21071N
|
FNC21071C
|
TCF7 |
transcription factor 7 (T-cell specific, HMG-box), transcript variant 1 |
FXC22279
|
FHC22279
|
FNC22279N
|
FNC22279C
|
CSNK2B |
casein kinase 2, beta polypeptide, transcript variant 1 |
FXC22554
|
FHC22554
|
FNC22554N
|
FNC22554C
|
CTNNA3 |
catenin (cadherin-associated protein), alpha 3, transcript variant 1 |
FXC23872
|
FHC23872
|
FNC23872N
|
FNC23872C
|
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic), transcript variant 4 |
FXC25083
|
FHC25083
|
FNC25083N
|
FNC25083C
|